NCT01952041View on ClinicalTrials.gov

A New Paradigm for Illness Monitoring and Relapse Prevention in Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

149

Participants

Timeline

Start Date

March 13, 2015

Primary Completion Date

August 7, 2017

Study Completion Date

August 7, 2017

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
BEHAVIORAL

Device: Smartphone

BEHAVIORAL

Treatment as usual

Trial Locations (1)

11004

Zucker Hillside Hospital, Glen Oaks

All Listed Sponsors
lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT01952041 - A New Paradigm for Illness Monitoring and Relapse Prevention in Schizophrenia | Biotech Hunter | Biotech Hunter